N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-[1,3,4-OXADIAZOL-2-YL]PHENYL)PYRIDINE-3-SULPHONAMIDE FOR THE TREATMENT OF CANCER

THE USE OF N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-[1,3,4-OXADIAZOL-2YL]PHENYL)PYRIDINE-3-SULPHONAMIDE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN THE TREATMENT OF CANCER AND/OR PAIN IN A WARM BLOODED ANIMAL SUCH AS MAN IS DESCRIBED.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DONNA JOHNSTONE, FRANCIS THOMAS BOYLE, SIAN TOMIKO TAYLOR, DAVID WILLIAM TONGE, ANDREW MARK HUGHES, NIGEL CHARLES BARRASS, MARIANNE BERNICE ASHFORD
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	THE USE OF N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-[1,3,4-OXADIAZOL-2YL]PHENYL)PYRIDINE-3-SULPHONAMIDE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN THE TREATMENT OF CANCER AND/OR PAIN IN A WARM BLOODED ANIMAL SUCH AS MAN IS DESCRIBED.